Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Pharmac Gearing Up For Broader Impact In Health Procurement


31 January 2013
Media release

Pharmac Gearing Up For Broader Impact In Health Procurement

PHARMAC is on track to meet targets set in relation to its expanded role with medical devices and hospital medicines.

The Government pharmaceutical funder is now responsible for community medicines, the national vaccine schedule, and will take over managing hospital medicines from July 2013 and hospital medical devices from 2015.

In the agency’s Annual Review, published today, Chief Executive Steffan Crausaz says PHARMAC is currently going through a growth phase as it increases its capacity to carry out these expanded functions.

PHARMAC’s successful record of managing community medicines and their funding has led to its expanded role, and Steffan Crausaz says past experience, coupled with expert input as it moves into less familiar areas like medical devices, will be vital to future success.

“Part of PHARMAC’s culture is that we are continually looking to past experience as we move into our next area of work. We learn from the past, use and adapt the strategies that have worked well, and change those that don’t,” he says.

With hospital medicines, PHARMAC is finalising the list of medicines all District Health Board hospitals will fund. The next step is to consult on and finalise the requirements for using hospital medicines, prior to a national list of hospital medicines being published for the first time on 1 July 2013. The objective of the hospital medicines work is to ensure access to hospital medicines is consistent across New Zealand, and that future additions or changes are managed. Longer-term additional savings are likely which will be available for investment in new medicines or other health services.

While PHARMAC’s medical devices work is longer-term, considerable work is already being done to give PHARMAC the capacity to manage the range of devices currently used by DHBs and to generate benefits for the health system right now.
PHARMAC’s work is part of a DHB-wide initiative being led by Health Benefits Ltd (HBL).
“While there are about 2000 products listed on the community Pharmaceutical Schedule, with medical devices is the range is far greater with some estimates putting the number of itemsat 250,000,” says Steffan Crausaz.

“As we heard at our national Forum last year, it’s a diverse area with a more rapid pace of change than pharmaceuticals, and we will need to adapt our approach to suit this difference in technologies. We’re very aware that in terms of procurement strategies, `one size fits all’ just won’t work.”

Medicine funding

PHARMAC’s Annual Review outlines the agency’s activity in funding medicines during 2011/12, with the community Schedule seeing 14 new medicines added, and a further 10 having funding access widened so more patients can have funding.

Key decisions included:

• Funding for the new-generation anti-coagulant dabigatran (Pradaxa) – gross spending (subject to a confidential rebate) was $16 million in the first year.
• Widened access to rituximab (Mabthera) for chronic lymphocytic leukaemia,
• Funding lapatanib (Tykerb) for advanced HER2-positive breast cancer
• Funding pazopanib (Votrient) for advanced kidney cancer.
• Funding raloxifene and teriparatide for osteoporosis

Major savings decisions included those for widely-used cardiovascular treatments atorvastatin, metoprolol and felodipine were forecast to save more than $50 million over three years.

Diabetes testing equipment

Decisions to fund new blood glucose meters and insulin pumps for diabetes management have been a major project. In early 2012 PHARMAC had one of the largest responses ever to its consultation (around 3000 responses), and made changes to its proposals as a result when decisions were made in late 2012.

Steffan Crausaz says the meter change has been going well since it began on 1 September 2012 and is being supported by one of the most comprehensive patient implementation campaigns ever managed by PHARMAC.

The programme includes information for doctors, pharmacists, practice nurses and patients; 0800 numbers run by PHARMAC and the supplier of the new meters, Pharmaco; online training modules for health professionals and a patient information programme called Meet Your Meter. PHARMAC is also paying Brand Switch Payments to pharmacies to help them manage patients’ changes to the new meters.

20-year highlights

The Annual Review also outlines highlights of PHARMAC’s first 20 years and some of the ways the agency has changed over the years, such as in relation to how it uses different purchasing strategies, the way it has engaged the clinical community and consumer sector, how patent changes and emerging technologies like biosimilars may impact on future work, and some of the significant changes in pharmaceutical technology over the past 20 years.

Steffan Crausaz says: “There’s no doubt PHARMAC will need to adapt and be agile to adjust to the ever-changing landscape it will be operating in. There have always been high expectations on PHARMAC’s ability to deliver, and these expectations will be even higher in future.”

“The organisation will grow, and we will have to make sure our internal systems and structures are well suited to the work ahead of us, and that they enable us to keep meeting our objectives.”

“One thing is certain – how PHARMAC looks and acts in five years is likely to be quite different to how it looks and acts today.”

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Fairfax Moves To Create Modern Newsroom

Fairfax Media New Zealand continues its newsroom transformation this week, with a proposal to further organise its editorial operations into focused, local teams and specialist national topic areas. More>>

ALSO:

Dairy: Fonterra Forecast For 2015/16 Season

Fonterra Co-operative Group Limited has today reduced its forecast Farmgate Milk Price for the 2014/15 season to $4.40 per kgMS. Along with its previously announced forecast dividend range of 20-30 cents per share, the change amounts to a forecast ... More>>

ALSO:

BusinessDesk: SkyCity Lifts Minimum Convention Centre Investment To $430M

SkyCity Entertainment Group, the casino operator, has lifted the minimum it will invest in the Auckland International Convention Centre to $430 million and said total costs including land may be $450 million to $470 million. More>>

Statistics: Drop In Dairy Prices Leads Fall In Exports

Total goods exports fell $240 million (5.5 percent) to $4.2 billion in April 2015 compared with April 2014, Statistics New Zealand said today. More>>

BusinessDesk: APN's NZME Sees Future In Paywalls, Growth In Digital Sales

APN News & Media has touted a single newsroom concept for its NZME unit in New Zealand, similar to what Germany's Die Welt uses, saying an 'integrated sales proposition' is helping it win market share, including ... More>>

Labour Party: Global Milk Prices Now Lowest In 6 Years

The latest fall in the global dairy price has brought it to the lowest level in six years and shows there must be meaningful action in tomorrow’s Budget to diversify the economy, says Labour’s Finance spokesperson Grant Robertson. “Dairy prices ... More>>


BusinessDesk: NZ Inflation Expectations Creep Higher In June Survey

May 19 (BusinessDesk) - New Zealand businesses lifted their expectations for inflation over the next two years, sapping any immediate pressure on the Reserve Bank to cut interest rates, and prompting the kiwi dollar to jump higher. More>>

BusinessDesk: Lower Fuel Costs Drive Down NZ Producer Input, Output Prices

May 19 - Producer input and output prices fell in the first quarter, mainly reflecting lower fuel costs and weakness in prices of meat and dairy products. More>>

Media: Fairfax Media NZ Announces Senior Editorial Team

Fairfax Media New Zealand has today confirmed its new editorial leadership team, as part of a transformation of its newsrooms aimed at enhancing local and national journalism across digital and print. More>>

Science: Flavonoids Reduce Cold And Cough Risk

Flavonoids reduce cold and cough risk Research from the University of Auckland shows eating flavonoids – found in green tea, apples, blueberries, cocoa, red wine and onions – can significantly reduce the risk of catching colds and coughs. The research, ... More>>

BusinessDesk: RBNZ House Alert Speech The Catalyst For Government Action

Prime Minister John Key all but conceded that pressure from the Reserve Bank of New Zealand for concerted action on rampant Auckland house prices was one of the main catalysts for the government's weekend announcements about tightly ... More>>

BusinessDesk: How To Fall Foul Of The New Housing Tax Rules: Tips From IRD

Just because you rented out your investment property doesn't absolve you from paying tax, says the Inland Revenue Department in a summary of commonly made mistakes by non-professional property investors when it comes to their tax liability.More>>

Legal: Superdiversity Law, Policy And Business Stocktake Announced

Mai Chen, Managing Partner at Chen Palmer New Zealand Public and Employment Law Specialists and Adjunct Professor of Law at the University of Auckland, today announced the establishment ... More>>

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news